Surgical Department, ICMDM, Hospital Clínic de Barcelona, Barcelona, Spain.
HPB (Oxford). 2012 Mar;14(3):171-6. doi: 10.1111/j.1477-2574.2011.00422.x. Epub 2012 Jan 9.
Non-functional endocrine pancreatic tumours (NPT) of more than 2 cm have an increased risk of malignancy. The aim of the present study was: (i) to define the guidelines for laparoscopic enucleation (LapEn) in patients with a non-functional NPT ≤3 cm in diameter; (ii) to evaluate pancreas-related complications; and (iii) to present the long-term outcome.
Between April 1998 and September 2010, 30 consecutive patients underwent laparoscopic surgery for a non-functional NPT (median age 56.5 years, range 44-83). Only 13 patients with tumours ≤3 cm in size underwent LapEn. Local lymph node dissection to exclude lymph node involvement was performed in all patients.
The median tumour size, operative time and blood loss were 2.8 cm (range 2.8-3), 130 min (range 90-280) and 220 ml (range 120-300), respectively. A pancreatic fistula occurred in five patients: International Study Group of Pancreatic Fistula (ISGPF) A in two patients and ISGPF B in three patients. The median follow-up was 48 months (12-144). Three patients with well-differentiated carcinoma are free of disease 2, 3 and 4 years after LapEn and a regional lymphadenectomy. One patient, 5 years after a LapEn, presented with lymph node and liver metastases.
The present study confirms the technical feasibility and acceptable morbidity associated with LapEn. Intra-operative lymph node sampling and frozen-section examination should be performed at the time of LapEn; when a malignancy is confirmed, oncologically appropriate lymph node dissection should be performed.
直径超过 2 厘米的无功能性胰腺内分泌肿瘤(NPT)恶性风险增加。本研究的目的是:(i)确定直径≤3 厘米的无功能性 NPT 患者行腹腔镜剜除术(LapEn)的指南;(ii)评估胰腺相关并发症;以及(iii)介绍长期结果。
1998 年 4 月至 2010 年 9 月期间,30 例连续患者因无功能性 NPT 而行腹腔镜手术(中位年龄 56.5 岁,范围 44-83 岁)。仅 13 例肿瘤直径≤3 厘米的患者行 LapEn。所有患者均行局部淋巴结清扫术以排除淋巴结受累。
肿瘤大小、手术时间和出血量的中位数分别为 2.8 厘米(范围 2.8-3)、130 分钟(范围 90-280)和 220 毫升(范围 120-300)。5 例患者发生胰瘘:国际胰腺瘘研究组(ISGPF)A 级 2 例,ISGPF B 级 3 例。中位随访时间为 48 个月(12-144)。3 例分化良好的癌患者在 LapEn 和区域淋巴结清扫术后 2、3 和 4 年无疾病。1 例患者在 LapEn 后 5 年出现淋巴结和肝转移。
本研究证实了 LapEn 的技术可行性和可接受的发病率。LapEn 时应进行术中淋巴结取样和冷冻切片检查;当确认为恶性肿瘤时,应进行适当的淋巴结清扫术。